<table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<thead>
<tr>
<th style='font-weight: 900; border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>rowname</th>
<th style='font-weight: 900; border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>chng_type</th>
<th style='font-weight: 900; border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>NOS_ID</th>
<th style='font-weight: 900; border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>NOS_Name</th>
<th style='font-weight: 900; border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>NOS_MOI</th>
<th style='font-weight: 900; border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>NOS_Gene</th>
<th style='font-weight: 900; border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>HGNC_symbol</th>
<th style='font-weight: 900; border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>NOS_OMIM</th>
<th style='font-weight: 900; border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>AZ_Comments</th>
<th style='font-weight: 900; border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>PMID</th>
<th style='font-weight: 900; border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>NOS_Notes</th>
<th style='font-weight: 900; border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>NOS_Group_Name</th>
</tr>
</thead>
<tbody>
<tr style='background-color: #ffffff;'>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>128</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>+</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>NOS 10-0470</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>Cranioectodermal dysplasia (Levin-Sensenbrenner), IFT40-related</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>AR</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>IFT40</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>IFT140</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>see 614620</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>typo</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>see short rib thoracic dysplasia, IFT140-associated, above</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>Skeletal disorders caused by abnormalities of cilia or ciliary signaling</td>
</tr>
<tr style='background-color: #ffffff;'>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>128</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'>-</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>NOS 10-0470</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>Cranioectodermal dysplasia (Levin-Sensenbrenner), IFT40-related</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>AR</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>IFT40</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>see 614620</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>see short rib thoracic dysplasia, IFT140-associated, above</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>Skeletal disorders caused by abnormalities of cilia or ciliary signaling</td>
</tr>
<tr style='background-color: #dedede;'>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>210</td>
<td style='padding: .2em; color: #52854C; background-color: #dedede; text-align: center;'>+</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>NOS 15-0110</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>Mesomelic dysplasia, HOXD-related (Kim or Korean type, Kantaputra type, Fryns type)</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>AD</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>HOXD</td>
<td style='padding: .2em; color: #52854C; background-color: #dedede; text-align: center;'>[HOXD11, HOXD12, HOXD13]</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>156232</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'></td>
<td style='padding: .2em; color: #52854C; background-color: #dedede; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>Duplications at HOXD gene cluster locus; phenotypes is variable also within families</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>Mesomelic and rhizo-mesomelic dysplasias</td>
</tr>
<tr style='background-color: #dedede;'>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>210</td>
<td style='padding: .2em; color: #FC4E07; background-color: #dedede; text-align: center;'>-</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>NOS 15-0110</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>Mesomelic dysplasia, HOXD-related (Kim or Korean type, Kantaputra type, Fryns type)</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>AD</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>HOXD</td>
<td style='padding: .2em; color: #FC4E07; background-color: #dedede; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>156232</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'></td>
<td style='padding: .2em; color: #FC4E07; background-color: #dedede; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>Duplications at HOXD gene cluster locus; phenotypes is variable also within families</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>Mesomelic and rhizo-mesomelic dysplasias</td>
</tr>
<tr style='background-color: #ffffff;'>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>319</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>+</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>NOS 22-0050</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>Mucopolysaccharidosis type 3, HGSNAT-related (type 3C)</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>AR</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>HSGNAT</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>HGSNAT</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>252930</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>typo</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>Known as Sanfilippo C syndrome</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>Lysosomal storage diseases with skeletal involvement</td>
</tr>
<tr style='background-color: #ffffff;'>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>319</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'>-</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>NOS 22-0050</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'>Mucopolysaccharidosis type 3, HSGNAT-related (type 3C)</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>AR</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>HSGNAT</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>252930</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>Known as Sanfilippo C syndrome</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>Lysosomal storage diseases with skeletal involvement</td>
</tr>
<tr style='background-color: #dedede;'>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>339</td>
<td style='padding: .2em; color: #52854C; background-color: #dedede; text-align: center;'>+</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>NOS 22-0250</td>
<td style='padding: .2em; color: #52854C; background-color: #dedede; text-align: center;'>Mucolipidosis, LYSET-related</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>AR</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>CGAF</td>
<td style='padding: .2em; color: #52854C; background-color: #dedede; text-align: center;'>LYSET</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>619345</td>
<td style='padding: .2em; color: #52854C; background-color: #dedede; text-align: center;'>typo</td>
<td style='padding: .2em; color: #52854C; background-color: #dedede; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>The gene was previously known as TMEM251 and encodes for a “GNTAP cleavage and activity factor” (see GNTAP, above)</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>Lysosomal storage diseases with skeletal involvement</td>
</tr>
<tr style='background-color: #dedede;'>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>339</td>
<td style='padding: .2em; color: #FC4E07; background-color: #dedede; text-align: center;'>-</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>NOS 22-0250</td>
<td style='padding: .2em; color: #FC4E07; background-color: #dedede; text-align: center;'>Mucolipidosis, GCAF-related</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>AR</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>CGAF</td>
<td style='padding: .2em; color: #FC4E07; background-color: #dedede; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>619345</td>
<td style='padding: .2em; color: #FC4E07; background-color: #dedede; text-align: center;'></td>
<td style='padding: .2em; color: #FC4E07; background-color: #dedede; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>The gene was previously known as TMEM251 and encodes for a “GNTAP cleavage and activity factor” (see GNTAP, above)</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>Lysosomal storage diseases with skeletal involvement</td>
</tr>
<tr style='background-color: #ffffff;'>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>347</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>+</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>NOS 23-0070</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>Rhizomelic CDP, GNPAT-related</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>AR</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>DHPAT</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>GNPAT</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>222765</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>typo</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>Chondrodysplasia punctata (CDP) group</td>
</tr>
<tr style='background-color: #ffffff;'>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>347</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'>-</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>NOS 23-0070</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'>Rhizomelic CDP, DHPAT-related</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>AR</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>DHPAT</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>222765</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>Chondrodysplasia punctata (CDP) group</td>
</tr>
<tr style='background-color: #dedede;'>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>439</td>
<td style='padding: .2em; color: #52854C; background-color: #dedede; text-align: center;'>+</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>NOS 26-0260</td>
<td style='padding: .2em; color: #52854C; background-color: #dedede; text-align: center;'>Osteogenesis imperfecta, progressively deforming (Sillence type 3), CCDC134-related</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>AR</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>CCD134</td>
<td style='padding: .2em; color: #52854C; background-color: #dedede; text-align: center;'>CCDC134</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>619795</td>
<td style='padding: .2em; color: #52854C; background-color: #dedede; text-align: center;'>typo</td>
<td style='padding: .2em; color: #52854C; background-color: #dedede; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>In OMIM as OI typeXXII</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>Osteogenesis imperfecta and bone fragility group</td>
</tr>
<tr style='background-color: #dedede;'>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>439</td>
<td style='padding: .2em; color: #FC4E07; background-color: #dedede; text-align: center;'>-</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>NOS 26-0260</td>
<td style='padding: .2em; color: #FC4E07; background-color: #dedede; text-align: center;'>Osteogenesis imperfecta, progressively deforming (Sillence type 3), CCD134-related</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>AR</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>CCD134</td>
<td style='padding: .2em; color: #FC4E07; background-color: #dedede; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>619795</td>
<td style='padding: .2em; color: #FC4E07; background-color: #dedede; text-align: center;'></td>
<td style='padding: .2em; color: #FC4E07; background-color: #dedede; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>In OMIM as OI typeXXII</td>
<td style='padding: .2em; color: #999999; background-color: #dedede; text-align: center;'>Osteogenesis imperfecta and bone fragility group</td>
</tr>
<tr style='background-color: #ffffff;'>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>695</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>+</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>NOS 38-0190</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>Engrailed-1 related dorsoventral syndrome (ENDOVES), limb-only type</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>AR</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>MAENLI</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>EN1*</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>619217</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'>no HGNC for MAENLI</td>
<td style='padding: .2em; color: #52854C; background-color: #ffffff; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>MAENLI is a lncRNA regulating EN1 expression</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; text-align: center;'>Limb hypoplasia—reduction defects group</td>
</tr>
<tr style='background-color: #ffffff;'>
<td style='padding: .2em; color: #999999; background-color: #ffffff; border-bottom: 2px solid grey; text-align: center;'>695</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; border-bottom: 2px solid grey; text-align: center;'>-</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; border-bottom: 2px solid grey; text-align: center;'>NOS 38-0190</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; border-bottom: 2px solid grey; text-align: center;'>Engrailed-1 related dorsoventral syndrome (ENDOVES), limb-only type</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; border-bottom: 2px solid grey; text-align: center;'>AR</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; border-bottom: 2px solid grey; text-align: center;'>MAENLI</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; border-bottom: 2px solid grey; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; border-bottom: 2px solid grey; text-align: center;'>619217</td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; border-bottom: 2px solid grey; text-align: center;'></td>
<td style='padding: .2em; color: #FC4E07; background-color: #ffffff; border-bottom: 2px solid grey; text-align: center;'></td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; border-bottom: 2px solid grey; text-align: center;'>MAENLI is a lncRNA regulating EN1 expression</td>
<td style='padding: .2em; color: #999999; background-color: #ffffff; border-bottom: 2px solid grey; text-align: center;'>Limb hypoplasia—reduction defects group</td>
</tr>
</tbody>
</table>